Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis - De Gottardi, Andrea; Trebicka, Jonel; Klinger, Christoph; Plessier, Aurélie; Seijo, Susana; Terziroli, Benedetta; Magenta, Lorenzo; Semela, David; Buscarini, Elisabetta; Langlet, Philippe; Görtzen, Jan; Puente, Angela; et al. (Liver international, 2017)
Keywords: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antagonists; Anticoagulants; Anticoagulants - adverse effects; Anticoagulants - therapeutic use; anticoagulation; Atrial Fibrillation - drug therapy; Bleeding; Budd‐Chiari syndrome; Cirrhosis; Clinical trials; Coagulation; Complications; Consortia; Data collection; Demographics; Europe; Female; Fibrillation; Gastrointestinal Hemorrhage - chemically induced; Heparin; Humans; Kidneys; Liver; Liver cirrhosis; Liver Cirrhosis - complications; Liver diseases; Male; Medical research; Middle Aged; Molecular weight; Patients; Portal vein; portal vein thrombosis; Renal function; Side effects; Splanchnic Circulation - physiology; Switching; Thromboembolism; Thrombosis; Venous Thrombosis - drug therapy; Vitamin K; Vitamin K - antagonists & inhibitors; Young Adult; Budd-Chiari syndrome; portal vein thrombosis; cirrhosis; anticoagulation